Literature DB >> 24472437

Interaction network mapping among IL-32 isoforms.

Jeong-Woo Kang1, Yun Sun Park1, Dong Hun Lee1, Man Sub Kim1, Yesol Bak1, Sun Young Ham1, Su Ho Park1, Heejong Kim1, Joong Hoon Ahn1, Jin Tae Hong2, Do-Young Yoon3.   

Abstract

IL-32 has been studied for its pleiotropic effects ranging from host immune responses to cell differentiation. Although several IL-32 isoforms have been characterized for their effects on cells, the roles of the others remain unclear. We previously reported that IL-32δ interacted with IL-32β and inhibited IL-32β-mediated IL-10 production. Thus, we performed comprehensive analyses to reveal more interactions between IL-32 isoforms in this study. We screened the interactions of 81 combinations of nine IL-32 isoforms by using a yeast two-hybrid assay, which identified 13 heterodimeric interactions. We verified these results by using reciprocal immunoprecipitation assays and reconfirmed 10 interactions, and presented the interaction network map between IL-32 isoforms. Our data suggest that IL-32 may have diverse intracellular effects through the interactions with its different isoforms.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  IL-32; Immunoprecipitation; Interaction map; Isoform interaction; Yeast two-hybrid

Mesh:

Substances:

Year:  2014        PMID: 24472437     DOI: 10.1016/j.biochi.2014.01.013

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  28 in total

1.  IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.

Authors:  Hanako Ohmatsu; Daniel Humme; Juana Gonzalez; Nicholas Gulati; Markus Möbs; Wolfram Sterry; James G Krueger
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

Review 2.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

3.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

4.  Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.

Authors:  Sarah M Zaidan; Louise Leyre; Rémi Bunet; Etienne Larouche-Anctil; Isabelle Turcotte; Mohamed Sylla; Annie Chamberland; Carl Chartrand-Lefebvre; Petronela Ancuta; Jean-Pierre Routy; Jean-Guy Baril; Benoit Trottier; Paul MacPherson; Sylvie Trottier; Marianne Harris; Sharon Walmsley; Brian Conway; Alexander Wong; Réjean Thomas; Robert C Kaplan; Alan L Landay; Madeleine Durand; Nicolas Chomont; Cécile L Tremblay; Mohamed El-Far
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-15       Impact factor: 3.731

Review 5.  Role of interleukin-32 in cancer biology.

Authors:  Haimeng Yan; Donghua He; Xi Huang; Enfan Zhang; Qingxiao Chen; Ruyi Xu; Xinling Liu; Fuming Zi; Zhen Cai
Journal:  Oncol Lett       Date:  2018-05-07       Impact factor: 2.967

6.  Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients.

Authors:  Shreyas Bhat; Nilesh Gardi; Sujata Hake; Nirupama Kotian; Sharada Sawant; Sadhana Kannan; Vani Parmar; Sangeeta Desai; Amit Dutt; Narendra N Joshi
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-03       Impact factor: 4.553

7.  Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A.

Authors:  Etiene Moreira Gabriel; Tomas Raul Wiche Salinas; Annie Gosselin; Etienne Larouche-Anctil; Madeleine Durand; Alan L Landay; Mohamed El-Far; Cécile L Tremblay; Jean-Pierre Routy; Petronela Ancuta
Journal:  AIDS       Date:  2021-10-01       Impact factor: 4.632

Review 8.  Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection.

Authors:  Yaqin Zhou; Ying Zhu
Journal:  Viruses       Date:  2015-06-16       Impact factor: 5.048

9.  IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.

Authors:  Man Sub Kim; Jeong-Woo Kang; Yun Sun Park; Dong Hun Lee; Yesol Bak; Taeho Kwon; Do-Young Yoon
Journal:  Oncotarget       Date:  2015-02-28

10.  Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.

Authors:  Thu-Huyen Pham; Hyo-Min Park; Jinju Kim; Jin-Tae Hong; Do-Young Yoon
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.